B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 550 KRW -0.26%
Market Cap: 425.1B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one BioPlus Co Ltd stock under the Base Case scenario is 15 813.61 KRW. Compared to the current market price of 7 550 KRW, BioPlus Co Ltd is Undervalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15 813.61 KRW
Undervaluation 52%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
BioPlus Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for BioPlus Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BioPlus Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

7 550 KRW
-0.26%
-0.26%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

BioPlus Co Ltd
KR
Health Care
Market Cap
425.1B KRW
IPO
Sep 27, 2021
Employees
-
Korea
Market Cap
425.1B KRW
Industry
Health Care
IPO
Sep 27, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about BioPlus Co Ltd

Provide an overview of the primary business activities
of BioPlus Co Ltd.

What unique competitive advantages
does BioPlus Co Ltd hold over its rivals?

What risks and challenges
does BioPlus Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioPlus Co Ltd.

Provide P/S
for BioPlus Co Ltd.

Provide P/E
for BioPlus Co Ltd.

Provide P/OCF
for BioPlus Co Ltd.

Provide P/FCFE
for BioPlus Co Ltd.

Provide P/B
for BioPlus Co Ltd.

Provide EV/S
for BioPlus Co Ltd.

Provide EV/GP
for BioPlus Co Ltd.

Provide EV/EBITDA
for BioPlus Co Ltd.

Provide EV/EBIT
for BioPlus Co Ltd.

Provide EV/OCF
for BioPlus Co Ltd.

Provide EV/FCFF
for BioPlus Co Ltd.

Provide EV/IC
for BioPlus Co Ltd.

Show me price targets
for BioPlus Co Ltd made by professional analysts.

What are the Revenue projections
for BioPlus Co Ltd?

How accurate were the past Revenue estimates
for BioPlus Co Ltd?

What are the Net Income projections
for BioPlus Co Ltd?

How accurate were the past Net Income estimates
for BioPlus Co Ltd?

What are the EPS projections
for BioPlus Co Ltd?

How accurate were the past EPS estimates
for BioPlus Co Ltd?

What are the EBIT projections
for BioPlus Co Ltd?

How accurate were the past EBIT estimates
for BioPlus Co Ltd?

Compare the revenue forecasts
for BioPlus Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioPlus Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioPlus Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioPlus Co Ltd compared to its peers.

Compare the P/E ratios
of BioPlus Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing BioPlus Co Ltd with its peers.

Analyze the financial leverage
of BioPlus Co Ltd compared to its main competitors.

Show all profitability ratios
for BioPlus Co Ltd.

Provide ROE
for BioPlus Co Ltd.

Provide ROA
for BioPlus Co Ltd.

Provide ROIC
for BioPlus Co Ltd.

Provide ROCE
for BioPlus Co Ltd.

Provide Gross Margin
for BioPlus Co Ltd.

Provide Operating Margin
for BioPlus Co Ltd.

Provide Net Margin
for BioPlus Co Ltd.

Provide FCF Margin
for BioPlus Co Ltd.

Show all solvency ratios
for BioPlus Co Ltd.

Provide D/E Ratio
for BioPlus Co Ltd.

Provide D/A Ratio
for BioPlus Co Ltd.

Provide Interest Coverage Ratio
for BioPlus Co Ltd.

Provide Altman Z-Score Ratio
for BioPlus Co Ltd.

Provide Quick Ratio
for BioPlus Co Ltd.

Provide Current Ratio
for BioPlus Co Ltd.

Provide Cash Ratio
for BioPlus Co Ltd.

What is the historical Revenue growth
over the last 5 years for BioPlus Co Ltd?

What is the historical Net Income growth
over the last 5 years for BioPlus Co Ltd?

What is the current Free Cash Flow
of BioPlus Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioPlus Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioPlus Co Ltd

Current Assets 96.1B
Cash & Short-Term Investments 69B
Receivables 13.5B
Other Current Assets 13.6B
Non-Current Assets 152.3B
Long-Term Investments 10.4B
PP&E 124.6B
Intangibles 6.5B
Other Non-Current Assets 10.8B
Current Liabilities 101.9B
Accounts Payable 1.1B
Accrued Liabilities 1B
Short-Term Debt 1.9B
Other Current Liabilities 97.8B
Non-Current Liabilities 17.1B
Long-Term Debt 2.6B
Other Non-Current Liabilities 14.4B
Efficiency

Earnings Waterfall
BioPlus Co Ltd

Revenue
53.5B KRW
Cost of Revenue
-22.1B KRW
Gross Profit
31.4B KRW
Operating Expenses
-15.3B KRW
Operating Income
16.1B KRW
Other Expenses
1.7B KRW
Net Income
17.8B KRW

Free Cash Flow Analysis
BioPlus Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

BioPlus Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive Operating Income
Positive Net Income
56/100
Profitability
Score

BioPlus Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

BioPlus Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
75/100
Solvency
Score

BioPlus Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
BioPlus Co Ltd

There are no price targets for BioPlus Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BioPlus Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BioPlus Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one BioPlus Co Ltd stock?

The intrinsic value of one BioPlus Co Ltd stock under the Base Case scenario is 15 813.61 KRW.

Is BioPlus Co Ltd stock undervalued or overvalued?

Compared to the current market price of 7 550 KRW, BioPlus Co Ltd is Undervalued by 52%.

Back to Top